Fractional photothermolysis versus triple therapy for the treatment of melasma: a randomised controlled trial

Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 20 人开始时间: 2008年3月4日最近更新: 2015年1月13日

试验速览

暂无简介。

•1. Adult patients with melasma
•2. Skin photo type II - V
•3. Subjects attending the outpatient department of the Netherlands Institute for Pigment Disorders
•4. Aged at least 18 years
•5. Subject is willing and able to give written informed consent

•1. Bleaching cream during the past four weeks
•2. Local corticosteroids during the past four weeks
•3. Subjects with a history of keloids
•4. Subjects with active eczema
•5. Subjects with active acne in the face
•6. Subjects with a history of facial eczema
•7. Suspect allergy to lidocaine or the triple therapy
•8. Use of roaccutane in the past six months
•9. Subjects not competent to understand what is involved
•10. Pregnancy
•11. Lesion suspicious for malignancy
•12. High exposure to sunlight (vacation in southern countries) or ultraviolet (UV) light (UVA or UVB)

发起方

Academic Medical Centre (AMC) (The Netherlands)